2. We select a group of 1,000 middle-aged volunteers without kidney disease who are likely to suffer from insomnia/anxiety. We assign them randomly into two groups. Group 1 is told to live their lives as normal and take any meds proscribed by their doctor. Group 2 is told not to use BZDS for 2 years, and doctors prescribe Group 2 with natural alternatives to BZDS. After those 2 years, we follow them up and check to see who developed kidney disease in each group, and compare the groups. 3. We will get the age-adjusted incidence rates of kidney disease in 30 different countries Jand compare those with the rates of BZD consumption per capita (total usage in country/ total population of that country). We will then check to see if there is a correlation between the BZD consumption and kidney disease. 4. In 2010, we examined the medical records of 2,000 patients ages 53+ associated with Kaiser Permanente (large health care organization) who did NOT have kidney disease in 2005. Then, we look back in the records to see who took BZDS from 2000-2005. After that, we look to see who developed kidney disease from 2006 until 2008. We compared the rates of kidney disease among those who took the BZDS and those who didn't.
2. We select a group of 1,000 middle-aged volunteers without kidney disease who are likely to suffer from insomnia/anxiety. We assign them randomly into two groups. Group 1 is told to live their lives as normal and take any meds proscribed by their doctor. Group 2 is told not to use BZDS for 2 years, and doctors prescribe Group 2 with natural alternatives to BZDS. After those 2 years, we follow them up and check to see who developed kidney disease in each group, and compare the groups. 3. We will get the age-adjusted incidence rates of kidney disease in 30 different countries Jand compare those with the rates of BZD consumption per capita (total usage in country/ total population of that country). We will then check to see if there is a correlation between the BZD consumption and kidney disease. 4. In 2010, we examined the medical records of 2,000 patients ages 53+ associated with Kaiser Permanente (large health care organization) who did NOT have kidney disease in 2005. Then, we look back in the records to see who took BZDS from 2000-2005. After that, we look to see who developed kidney disease from 2006 until 2008. We compared the rates of kidney disease among those who took the BZDS and those who didn't.
Glencoe Algebra 1, Student Edition, 9780079039897, 0079039898, 2018
18th Edition
ISBN:9780079039897
Author:Carter
Publisher:Carter
Chapter10: Statistics
Section10.6: Summarizing Categorical Data
Problem 27PPS
Related questions
Question
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
Recommended textbooks for you
Glencoe Algebra 1, Student Edition, 9780079039897…
Algebra
ISBN:
9780079039897
Author:
Carter
Publisher:
McGraw Hill
Holt Mcdougal Larson Pre-algebra: Student Edition…
Algebra
ISBN:
9780547587776
Author:
HOLT MCDOUGAL
Publisher:
HOLT MCDOUGAL
Calculus For The Life Sciences
Calculus
ISBN:
9780321964038
Author:
GREENWELL, Raymond N., RITCHEY, Nathan P., Lial, Margaret L.
Publisher:
Pearson Addison Wesley,
Glencoe Algebra 1, Student Edition, 9780079039897…
Algebra
ISBN:
9780079039897
Author:
Carter
Publisher:
McGraw Hill
Holt Mcdougal Larson Pre-algebra: Student Edition…
Algebra
ISBN:
9780547587776
Author:
HOLT MCDOUGAL
Publisher:
HOLT MCDOUGAL
Calculus For The Life Sciences
Calculus
ISBN:
9780321964038
Author:
GREENWELL, Raymond N., RITCHEY, Nathan P., Lial, Margaret L.
Publisher:
Pearson Addison Wesley,